A considerable amount of data sustains the involvement of FOXM1 in several features of breast cancer progression, such as the EMT, the migration and invasion abilities of tumor cells, in which FOXM1 controls the transcription of several metalloproteinases and the EMT inducer SNAI2 [58]. Here, SNAI2 is linked to breast carcinoma.